You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Promacta

Showing 1 - 25 of 31
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Severe Aplastic Anemia Trial run by the NHLBI (Cohort 1: hATG, CsA, EPAG Day 14 to Month 6, Cohort 2: hATG, CsA, EPAG Day 14 to

Recruiting
Has Results
  • Severe Aplastic Anemia
  • Cohort 1: hATG, CsA, EPAG Day 14 to Month 6
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 5, 2022

Healthy Volunteers Trial in San Francisco (Rosuvastatin, Rosuvastatin (Inhibitor arm), Eltrombopag)

Recruiting
  • Healthy Volunteers
  • San Francisco, California
    Ucsf Ctsi Crc
Nov 29, 2022

CLL, Leukemia Trial in Houston (Eltrombopag)

Completed
  • CLL
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 14, 2022

Bone Marrow Transplantation Recipient, Cord Blood Transplant Recipient, Hematopoietic Cell Transplantation Recipient Trial in

Active, not recruiting
  • Bone Marrow Transplantation Recipient
  • +2 more
  • Eltrombopag Olamine
  • Laboratory Biomarker Analysis
  • Houston, Texas
    M D Anderson Cancer Center
Feb 9, 2022

Severe Aplastic Anemia (SAA) Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Eltrombopag)

Active, not recruiting
Has Results
  • Severe Aplastic Anemia (SAA)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
May 12, 2021

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +4 more
  • Eltrombopag Olamine
  • Houston, Texas
    M D Anderson Cancer Center
Jan 4, 2022

Acute Myeloid Leukemia Trial in United States (Phase I- Cytarabine & Eltrombopag, Phase II- Sequence A, Phase II- Sequence B)

Terminated
Has Results
  • Acute Myeloid Leukemia
  • Phase I- Cytarabine & Eltrombopag
  • +2 more
  • Worcester, Massachusetts
  • +4 more
Oct 14, 2020

Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7) Trial in Atlanta,

Terminated
  • Adult Acute Basophilic Leukemia
  • +16 more
  • eltrombopag olamine
  • standard follow-up care
  • Atlanta, Georgia
  • +1 more
Jul 20, 2022

Adult Myelodysplastic Syndrome, Anemia, Chronic Myelomonocytic Leukemia Trial in Kansas City, Bronx (Eltrombopag Olamine,

Completed
  • Adult Myelodysplastic Syndrome
  • +2 more
  • Eltrombopag Olamine
  • +2 more
  • Kansas City, Kansas
  • +1 more
Mar 19, 2021

Anemia, Aplastic, Anemia, Hypoplastic, Thrombocytopenia Trial run by the NHLBI (Eltrombopag)

Completed
Has Results
  • Anemia, Aplastic
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 30, 2020

Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Basophilic Leukemia, Adult

Active, not recruiting
Has Results
  • Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
  • +18 more
  • eltrombopag olamine
  • Cleveland, Ohio
    Case Comprehensive Cancer Center
Nov 29, 2021

Leukemia Trial in Houston (Eltrombopag, Hypomethylating Agent (HMA))

Completed
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 5, 2020

Leukemia Trial in Houston (Eltrombopag, Decitabine)

Terminated
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 13, 2019

Thrombocytopenia, Hepatitis C Trial in Dallas (Eltrombopag)

Terminated
Has Results
  • Thrombocytopenia
  • Hepatitis C
  • Dallas, Texas
    UT Southwestern Medical Center
Oct 30, 2019

Thrombocytopenia Trial in Houston (Eltrombopag, Placebo)

Completed
Has Results
  • Thrombocytopenia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jul 8, 2019

Immune Thrombocytopenia, Platelet Disorder Trial in New York (Eltrombopag, Placebo)

Completed
Has Results
  • Immune Thrombocytopenia
  • Platelet Disorder
  • New York, New York
    Weill Cornell Medicine
May 20, 2019

Wiskott-Aldrich Syndrome, Thrombocytopenia, Bleeding Trial in New York (Promacta, blood drawing in patients with WAS, blood

Terminated
Has Results
  • Wiskott-Aldrich Syndrome
  • +2 more
  • Promacta
  • +2 more
  • New York, New York
    Weill Cornell Medical College
Mar 15, 2019

Immune Thrombocytopenia Trial in New York (Eltrombopag, Romiplostim, healthy controls)

Completed
Has Results
  • Immune Thrombocytopenia
  • New York, New York
    Weill Cornell Medical College
Mar 15, 2019

MDS, Thrombocytopenia Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Eltrombopag)

Completed
Has Results
  • Myelodysplastic Syndromes
  • Thrombocytopenia
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 8, 2022

End of EXTEND: Discontinuation of Medication for Immune

Terminated
  • Immune Thrombocytopenia
  • Discontinuation of eltrombopag
  • New York, New York
    Weill Cornell Medical College/New York Presbyterian Hospital
Jul 13, 2018

Idiopathic Thrombocytopenic Purpura Trial in Watertown (Eltrombopag, Avatrombopag, Standard of care)

Terminated
Has Results
  • Idiopathic Thrombocytopenic Purpura
  • Watertown, South Dakota
    Prairie Lakes Health Care System
Jan 9, 2018

Purpura, Thrombocytopaenic, Idiopathic Trial (Eltrombopag)

Completed
  • Purpura, Thrombocytopaenic, Idiopathic
  • (no location specified)
Jul 22, 2016

LENS - Long-term Eltrombopag Observational Study

Completed
  • Purpura, Thrombocytopaenic, Idiopathic
  • Tucson, Arizona
  • +71 more
Mar 21, 2017

Thrombocytopaenia Trial in Worldwide (eltrombopag, )

Completed
Has Results
  • Thrombocytopaenia
  • Phoenix, Arizona
  • +119 more
May 2, 2017

Chronic Lymphocytic Leukemia, Thrombocytopenia Trial in Austria, Germany (Placebo, Eltrombopag)

Terminated
  • Chronic Lymphocytic Leukemia
  • Thrombocytopenia
  • Vienna, Austria
  • +9 more
May 27, 2015